Patent · US Active

Compositions comprising 15-HEPE and methods of treating or preventing hematologic disorders, and/or related diseases

US12076304B2 · kind B2 · utility

0Cited by
62References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 6, 2022
Grant dateSep 3, 2024
Priority date
Expiry dateSep 7, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K9/0053
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to methods of treating or preventing hematologic disorders by administration of 15-HEPE or compositions thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.